Beilstein J. Org. Chem. 2018, 14, 194–202.
ORCID® iDs
133.13, 133.30, 141.92, 143.59, 147.24, 150.26; EIMS m/z (%):
450 (31), 229 (22), 448 (73), 405 (18), 357 (12), 345 (13), 343
(12), 342 (13), 341 (37), 340 (12), 339 (12), 309 (15), 308 (21),
307 (65), 306 (62), 305 (74), 293 (17), 292 (10), 291 (10), 278
(10), 267 (42), 266 (23), 265 (100), 251 (13), 229 (13), 224
(11), 216 (11), 215 (19), 101 (30), 91 (10), 85 (17), 83 (16), 77
(19), 72 (15), 71 (22), 69 (11), 57 (39), 56 (11), 55 (44), 43.5
(34), 41.5 (28), 39.5 (11); HRMS (EI) m/z: calcd for
C25H21N2O2S35Cl*+, 448.1012; found, 448.1015.
References
1. Lavrado, J.; Moreira, R.; Paulo, A. Curr. Med. Chem. 2010, 17,
2. Dwuma-Badu, D.; Ayim, J. S. K.; Fiagbe, N. I. Y.; Knapp, J. E.;
Schiff, P. L., Jr.; Slatkin, D. J. J. Pharm. Sci. 1978, 67, 433–434.
3. Cimanga, K.; De Bruyne, T.; Pieters, L.; Claeys, M.; Vlietinck, A.
Tetrahedron Lett. 1996, 37, 1703–1706.
Reactions of N-Boc protected indol-2-ylmethyl derivatives
with active nitroarenes (one-pot procedure). Typical proce-
dure. Synthesis of 5,6-di(tert-butoxycarbonyl)indolo[2,3-
b][1,7]naphthiridine (15). 3-Nitropyridine (0.15 g, 1.2 mmol)
and tert-butyl 1-(tert-butoxycarbonyl)indol-2-ylacetate (1b,
0.33 g, 1 mmol) were dissolved in 5 mL of MeCN. The resulted
mixture was stirred at room temperature until dissolution, then
were added TMSCl (0.65 g, 6 mmol) in one portion and DBU
(0.91 g, 6 equiv) dropwise (during 1 min). The reaction vial was
stoppered and the mixture stayed without stirring at room tem-
perature. Progress of the reaction was examined by tlc. After
completion of the reaction the mixture was poured onto satu-
rated aqueous NH4Cl solution (30 mL), extracted with EtOAc
(5 × 25 mL), the combined extract was washed with brine
(50 mL), dried over Na2SO4 and evaporated. The crude prod-
uct was purified by column chromatography (silica gel, EtOAc/
toluene: 1:10, then 1:5, then 1:2). Yellow solid, yield 167 mg
(40%); mp 168–170 °C (EtOAc/hexane; then washed with
pentane); IR (KBr): 3032, 3005, 2974, 2933, 2909, 2877, 1739
(CO), 1725 (CO), 1620, 1592, 1572, 1484, 1461, 1387, 1369,
1343, 1311, 1294, 1242, 1208 cm−1; 1H NMR (500 MHz,
CDCl3) δ 1.77 (s, 9H), 1.78 (s, 9H), 7.50 (t, J = 7.5 Hz, 1H),
7.67 (td, J = 7.8, 1.1 Hz, 1H), 8.11–8.15 (m, 2H), 8.47 (d,
J = 7.6 Hz, 1H), 8.65 (d, J = 5.8 Hz, 1H), 9.66 (s, 1H);
13C NMR (125 MHz, CDCl3) δ 28.40, 28.56, 83.97, 85.66,
116.31, 117.53, 121.99, 123.55, 124.35, 124.38, 127.16, 128.99,
131.53, 140.73, 142.28, 143.37, 149.70, 150.50, 154.09, 163.93.
HRMS (ESI) m/z: calcd for C24H26N3O4+, 420.1923.; found,
420.1917.
4. Paulo, A.; Figueiras, M.; Machado, M.; Charneira, C.; Lavrado, J.;
Santos, S. A.; Lopes, D.; Gut, J.; Rosenthal, P. J.; Nogueira, F.;
Moreira, R. J. Med. Chem. 2014, 57, 3295–3313.
5. Subbaraju, G. V.; Kavitha, J.; Rajasekhar, D.; Jimenez, J. I.
6. Ou, T.-M.; Lu, Y.-J.; Zhang, C.; Huang, Z.-S.; Wang, X.-D.; Tan, J.-H.;
Chen, Y.; Ma, D.-L.; Wong, K.-Y.; Tang, J. C.-O.; Chan, A. S.-C.;
Gu, L.-Q. J. Med. Chem. 2007, 50, 1465–1474.
7. Le Sann, C.; Huddleston, J.; Mann, J. Tetrahedron 2007, 63,
8. Lavrado, J.; Moreira, R.; Paulo, A. Synthetic strategies towards
bioactive indolo[3,2-b]quinolines. In Heterocyclic Targets in Advanced
Organic Synthesis; do Carmo Carreiras, M.; Marco-Contelles, J., Eds.;
Research Signpost: Trivandrum, 2011; pp 109–124.
9. Gorlitzer, K.; Ventzke-Neu, K. Pharmazie 1997, 52, 919–926.
10.Fichter, F.; Boehringer, R. Ber. Dtsch. Chem. Ges. 1906, 39,
11.Armit, J. W.; Robinson, R. J. Chem. Soc., Trans. 1922, 121, 827–839.
12.Holt, S. J.; Petrow, V. J. Chem. Soc. 1948, 922–924.
13.Cooper, M. M.; Lovell, J. M.; Joule, J. A. Tetrahedron Lett. 1996, 37,
14.Csányi, D.; Timári, G.; Hajós, G. Synth. Commun. 1999, 29,
15.Dutta, B.; Some, S.; Ray, J. K. Tetrahedron Lett. 2006, 47, 377–379.
16.Ablordeppey, S. Y.; Fan, P.; Clark, A. M.; Nimrod, A.
Bioorg. Med. Chem. 1999, 7, 343–349.
17.Fan, P.; Ablordeppey, S. Y. J. Heterocycl. Chem. 1997, 34,
Supporting Information
18.Arzel, E.; Rocca, P.; Marsais, F.; Godard, A.; Quéguiner, G.
Tetrahedron Lett. 1998, 39, 6465–6466.
Supporting Information File 1
19.Garrett, C. E.; Prasad, K. Adv. Synth. Catal. 2004, 346, 889–900.
Experimental part and copies of NMR spectra.
20.Mąkosza, M.; Wojciechowski, K. Chem. Rev. 2004, 104, 2631–2666.
21.Mąkosza, M.; Wojciechowski, K. Heterocycles 2014, 88, 75–101.
Acknowledgements
This work was financially supported by National Scientific
22.Mąkosza, M.; Wojciechowski, K. Top. Heterocycl. Chem. 2013, 37,
Center grant No 2012/07/B/ST5/00813.
201